top of page

Gain Competitive Advantage and Realize Improved Business Outcomes (Cost, Quality, Time to Market) with a Proven Management Consultancy, Digital Transformation and Strategic Sourcing / Outsourcing Advisory Firm

Life Sciences Sourcing Advisory and Consultancy Services (LS-SACS) is a unique firm that effectively combines deep life sciences functional domain, global operations and sourcing experience WITH Management Consulting expertise across strategy, operational excellence, IT and digital transformation, program management and organizational change and communications.    
Our customized and collaborative approach will deliver
reduced time to market, cost of operations and improved quality, productivity and customer satisfaction to our customers.  Our clients include small, medium and large life sciences clients as well as technology product vendors, and global BPO, CRO and IT service providers   

Our Strategic sourcing and outsourcing services are designed to deliver sustainable global and regional partnerships, improved quality and compliance, reduced cycle times and cost and transform the sourcing / outsourcing processes  within small, medium and large life sciences clients 

Our Management Consultancy Services cover Business and functional strategy, Hybrid and Decentralized Clinical Trials operations and technology services, Business operations and performance, People and organizational change, IT Strategy and Digital Transformation Services.  Core functional areas include Clinical Operations, Clinical Data Services, Pharmacovigilance,  Regulatory Operations and other areas and will ensure  improved quality, productivity, safety and patients' satisfaction, decreased cycle time and cost of operations.

lifesciencestransformationgroup

Article:  Best Practices to Ensure Sourcing and Outsourcing Are Strategic Levers for Competitive Advantage, Pharmexec.com, May 17, 2022

Companies have outsourced business process management/services and technology primarily as a cost-saving strategy over the past decade.  Increasingly, organizations have been leveraging their partners for operational improvements, such as automation and migration to cloud. The trend is further shifting as they plan to accelerate transformation projects and anticipate relying on service providers more heavily in the future. This approach is complementary to their strategy of building their internal capabilities across people, process, and technology for driving strategic innovation and transformation programs.  Sourcing and outsourcing can provide significant contributions to a pharmaceutical company’s competitive growth objectives, provided they are considered strategic and designed, and implemented from this perspective.

Articles and Case Studies

Article:  Best Practices in Utilizing the FSP model: Clinical Operations, Pharmacovigilance, Regulatory and Other Areas, Applied Clinical Trials, November 16, 2021

The COVID-19 pandemic has shown that there’s a lot more flexibility in clinical trial systems than what was realized in the past. It has been a catalyst in speeding the digital process, making virtual trial conduct becoming a reality. To continue the momentum, life sciences companies need to have a dependable set of global and regional external partnerships that are flexible and scalable. These partnership models (e.g., CROs and FSPs) need to fit the diverse needs of small, medium, and large companies and a variety of “future-ready” operating models that can span clinical operations and associated functions (e.g., Clinical Data Services, PV, regulatory).  The engagement model can be either FTE (cost of resource/hour) or unit/deliverables based (e.g., number of Case Report Forms (CRF), Tables, Listings, Figures (TLF), PV cases, and number of visits). In an environment where sponsors are challenged to manage their staffing capacity..., 

Article:  Best Practices For Sourcing & Outsourcing In Clinical Operations, Clinical Leader, Guest Column, October 21, 2021

The life sciences industry is in the throes of innovation and transformation.  Targeted therapeutic approaches for cancer and rare diseases and rapidly evolving genomics and molecular medicine approaches are translating into
precision medicines and individualized therapeutic protocols. Gene therapy and gene editing are beginning to transform the industry at a fundamental level.  Decentralized clinical trials (DCT) are aiding the transformation, facilitating a patient-centric approach, and leveraging a variety of digital technologies. Recent application of mRNA-based platforms and expeditious trials and submissions have led to the approval of highly effective vaccines for COVID-19.....

Case Study:  Sourcing strategy and RFP process for selecting digital clinical systems integrators and product vendors for a major pharma 

A major pharma company had developed a future clinical vision and wanted to identify the most optimal mix of systems integrators and digital clinical operations platform vendors to implement their strategy.  LS-SACS worked in collaboration with the client and a leading Third Party sourcing advisory and consulting firm, in identifying the vendors that had the capabilities and vision / plan to align with the client's future clinical vision.  We delivered the most optimal RFP design and structure, joint solution, contracting, negotiation and customized scoring.   

   

CONTACT US

Life Sciences - Sourcing Advisory and Consultancy Services (LS-SACS)

Edison, New New Jersey, USA

Email: krishnan.rajagopalan@ls-sacs.com

bottom of page